BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37458958)

  • 1. Construction of a hepatocytes-related and protein kinase-related gene signature in HCC based on ScRNA-Seq analysis and machine learning algorithm.
    Zhang Z; Mou L; Pu Z; Zhuang X
    J Physiol Biochem; 2023 Nov; 79(4):771-785. PubMed ID: 37458958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis.
    Mou L; Pu Z; Luo Y; Quan R; So Y; Jiang H
    Front Immunol; 2023; 14():1036562. PubMed ID: 36936948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework.
    Feng Q; Huang Z; Song L; Wang L; Lu H; Wu L
    Eur J Med Res; 2023 Aug; 28(1):306. PubMed ID: 37649103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.
    Chen J; Gao G; He Y; Zhang Y; Wu H; Dai P; Zheng Q; Huang H; Weng J; Zheng Y; Huang Y
    Sci Rep; 2023 Dec; 13(1):22624. PubMed ID: 38114725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
    Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
    Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of endothelial cell-related and autophagy-related prognostic models for hepatocellular carcinoma based on single-cell data.
    Mou L; Li K; Xu C; Xu I; Yang Y; Pu Z
    J Gastroenterol Hepatol; 2023 May; 38(5):809-820. PubMed ID: 36894323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
    Zhang X; Zhuge J; Liu J; Xia Z; Wang H; Gao Q; Jiang H; Qu Y; Fan L; Ma J; Tan C; Luo W; Luo Y
    Front Immunol; 2023; 14():1153423. PubMed ID: 37006285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrosome amplification-related signature correlated with immune microenvironment and treatment response predicts prognosis and improves diagnosis of hepatocellular carcinoma by integrating machine learning and single-cell analyses.
    Liu Y; He M; Ke X; Chen Y; Zhu J; Tan Z; Chen J
    Hepatol Int; 2024 Feb; 18(1):108-130. PubMed ID: 37154991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing.
    Fan L; Xu L; Tian S; Zheng X
    Front Endocrinol (Lausanne); 2022; 13():965445. PubMed ID: 36120466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinical significance and molecular characteristics of methionine metabolism and macrophage-related patterns in hepatocellular carcinoma based on machine learning.
    Wen D; Wang S; Yu J; Yu T; Liu Z; Li Y
    Cancer Biomark; 2024; 39(1):37-48. PubMed ID: 37522195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
    Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
    Front Immunol; 2022; 13():990790. PubMed ID: 36248822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.